Our endorsement programme has now closed
faecal calprotectin in primary care as a decision diagnostic for inflammatory bowel disease and irritable bowel syndrome A consensus...
faecal calprotectin in primary care as a decision diagnostic for inflammatory bowel disease and irritable bowel syndrome A consensus...
PredictSURE IBD and IBDX tests in identifying people at high or low risk of following a severe course of Crohn's disease how PredictSURE...
Evidence-based recommendations on PredictSURE IBD and IBDX for guiding treatment of Crohn’s disease
NICE has developed a medtech innovation briefing (MIB) on The Insides System for managing intestinal failure
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and secondary tumours (metastatic disease).
This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.
NICE has developed a medtech innovation briefing on Immunoscore for predicting risk of colon cancer relapse
gastroenterology and dermatology, including at an event for the National IBD audit. Implementing up-to-date high-quality research...
and over with ulcerative colitis or Crohn's disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to...
NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids
Evidence-based recommendations on bioprosthetic plug insertion for anal fistula in adults. This involves putting a plug into the fistula and stitching it in
Evidence-based recommendations on collagen paste for closing an anal fistula in adults
This guideline covers managing ulcerative colitis in children, young people and adults. It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.
Evidence-based recommendations on endoscopic ablation for an anal fistula in adults
We have temporarily withdrawn this medtech innovation briefing to update the information with regard to further research in this area.
Evidence-based recommendations on radially emitting laser fibre treatment of an anal fistula in adults
guidance DG11, for the detection of inflammation in the bowel (i.e. IBS vs IBD). Uptake of this guidance has previously been poor and...
Victoria Hilton and her team, finalists of the NICE Shared Learning Awards, tell us about an improved care pathway to support better outcomes for patients with gastrointestinal problems
NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory
Evidence-based recommendations on faecal immunochemical tests (OC Sensor, HM-JACKarc, FOB Gold and RIDASCREEN) to guide GP referral for colorectal cancer
NICE has developed a medtech innovation briefing (MIB) on RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease
Following NICE recommendations, patients with Crohn’s disease will have routine NHS access to drug ustekinumab, which offers a new way of treating the condition.
This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice on what action to take when people with signs and symptoms first present in healthcare settings. It also provides advice on the range of treatments available.
Evidence-based recommendations on virtual chromoendoscopy (VCE) using NBI, FICE or i-scan to assess colorectal polyps of 5 mm or less during colonoscopy
This guideline covers diagnosing and managing irritable bowel syndrome (IBS) in people aged 18 and over. It details how to accurately diagnose IBS, and aims to improve the quality of life for adults with IBS by promoting effective management using dietary and lifestyle advice, pharmacological therapy and referral for psychological interventions.
This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.
Evidence-based recommendations on integrated multiplex polymerase chain tests (xTAG Gastrointestinal Pathogen Panel, FilmArray GI Panel and Faecal Pathogens B
history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas? CG118/2
prospective study, for local audit, or for submission to a registry. (The IBD Registry is being adapted to receive data on TNF-alpha...
option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD) or irritable bowel...
Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits)
This quality standard covers diagnosing and managing irritable bowel syndrome in adults. It describes high-quality care in priority areas for improvement.
cancer is not suspected and it is used to support a diagnosis of inflammatory bowel disease (IBD) or irritable bowel...
Summary of the evidence on budesonide multimatrix (Cortiment) for treating ulcerative colitis (UC) to inform local NHS planning and decision-making
Although there is some observational evidence in people with inflammatory bowel disease (IBD), there is no evidence in...
and genetic markers, for colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas. Research should be...
that at least some causes of secondary osteoporosis (for example, inflammatory bowel disease) affect fracture risk by mechanisms that...
history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas? Any explanatory...
use of: - Biologics in Rheumatoid Arthritis(RA), Psoriasis & Inflammatory Bowel Disease (IBD) using NICE algorithms &...
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection
This quality standard covers diagnosing and managing inflammatory bowel disease (Crohn’s disease and ulcerative colitis) in adults, young people and children. It describes high-quality care in priority areas for improvement.
Evidence-based recommendations on inserting a collagen plug to close an abdominal wall enterocutaneous fistula
Evidence-based recommendations on negative pressure (vacuum therapy) wound therapy for the open (exposed) abdomen to aid healing
A simple stool test could help GPs decide whether patients have irritable bowel syndrome (IBS) or other more serious bowel conditions.
Evidence-based recommendations on faecal calprotectin tests for distinguishing between inflammatory bowel diseases (such as Crohn’s disease and ulcerative
Symptom relief through the range of recommended drugs and treatments available should be the primary outcome for patients with ulcerative colitis, according to NICE.
This guideline covers using colonoscopy to check for signs of bowel cancer in people aged 18 and over with ulcerative colitis or Crohn’s disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to prevent cancer and prolong life by offering advice on identifying early bowel cancer in adults most at risk.
Evidence-based recommendations on extracorporeal photopheresis (treated white blood cells) for Crohn's disease
This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis.
Evidence-based recommendations on leukapheresis for inflammatory bowel disease (IBD) (ulcerative colitis and Crohn's disease)